Futura Medical, the innovative healthcare company focused on advanced transdermal technology has been notified that on 10 January 2017, Jonathan Freeman, a Non-Executive Director, transferred 35,803 shares of 0.2p each in the Company (“Ordinary Shares”) from his personal holding into his Self-Invested Personal Pension account (“SIPP”).
The company said that the transaction consisted of the sale by Jonathan Freeman and the immediate on market re-purchase by Freeman’s SIPP of 35,803 Ordinary Shares at a price of 57.50p per share. There is no change to Freeman’s beneficial holding of the Company’s Ordinary Shares, which total 52,535 representing 0.04% of the Company’s issued share capital.